Healthcare / Medical Instruments & SuppliesUpdated 2026-05-10 22:07 UTC

IDX/MEDS stock hub

IDX/MEDS has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

IDX/MEDSis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

182.8B

Indonesia Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

IDX/MEDS

In the news

Latest news · IDX/MEDS

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 9.4P50 14.4P75 23.9

Trailing P/En/a

P25 11.5P50 23.8P75 52.6

ROE-12.1

P25 0.6P50 5.1P75 12.2

ROIC-12.5

P25 1.3P50 6P75 11.8

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All IDX/MEDS market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

172

Groups with data

Currency

IDR

Showing 172 of 172 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Indonesia
Country code	ID
Employees	16
Employees Change	-2%
Employees Change Percent	-11.11
Enterprise value	IDR 189.6B
Exchange	Indonesia Stock Exchange
Financial currency	IDR
First seen	2026-05-10
Industry	Medical Instruments & Supplies
Isin	ID1000171309
Last refreshed	2026-05-10
Market cap	IDR 182.8B
Price	IDR 117
Price currency	IDR
Rev Per Employee	598,911,284x
Sector	Healthcare
Sic	3842
Symbol	idx/MEDS
Website	https://www.evoplusmed.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-3.41%
EV Earnings	-30.39x
EV/FCF	-38.78x
EV/Sales	19.79x
FCF yield	-2.67%
P/B ratio	3.76x
P/S ratio	19.08x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-72.29%
EBITDA Margin	-31.06%
Gross margin	19.23%
Gross Profit	IDR 1.8B
Gross Profit Growth Q	832.93%
Gross Profit Growth3 Y	-55.58%
Net Income	IDR -6.2B
Net Income Growth Quarters	1%
Net Income Growth Years	1%
Pretax Margin	-67.42%
Profit Margin	-65.1%
Profit Per Employee	IDR -389.9M
ROA	-6.74
Roa5y	7.84
ROCE	-13.93
ROE	-12.06
Roe5y	16.46
ROIC	-12.49
Roic5y	18.82

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	134.14%
Cagr3y	7.19%
EPS Growth Quarters	1
EPS Growth Years	1
Revenue Growth	184.54x
Revenue Growth Q	162.83x
Revenue Growth Quarters	3x
Revenue Growth Years	1x
Revenue Growth3 Y	-36.68x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	IDR 0.15
Assets	IDR 63.8B
Cash	IDR 177.5M
Current Assets	IDR 16.8B
Current Liabilities	IDR 14.1B
Debt	IDR 7B
Debt Equity	IDR 0.14
Debt FCF	IDR -1.42
Equity	IDR 48.6B
Interest Coverage	-9.84
Liabilities	IDR 15.2B
Long Term Assets	IDR 47B
Long Term Liabilities	IDR 1.1B
Net Cash	IDR -6.8B
Net Cash By Market Cap	IDR -3.71
Net Debt Equity	IDR 0.14
Tangible Book Value	IDR 48.6B
Tangible Book Value Per Share	IDR 31.12
WACC	10.58

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.19
Inventory Turnover	0.63
Net Working Capital	IDR 8.8B
Quick ratio	0.26
Working Capital	IDR 2.7B
Working Capital Turnover	IDR 1.6

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	0.32%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	134%
200-day SMA	68.97
3Y total return	23.16%
50-day SMA	69.7
50-day SMA vs 200-day SMA	50over200
All Time High	520
All Time High Change	-77.5%
All Time High Date	2022-08-23
All Time Low	50
All Time Low Change	134%
All Time Low Date	2023-10-31
ATR	8.61
Beta	1.17
Beta1y	1.39
Beta2y	0.8
Ch YTD	64.79
High	117
High52	117
High52 Date	2026-05-08
High52ch	0%
Low	86
Low52	50
Low52 Date	2025-08-27
Low52ch	134%
Ma50ch	67.86%
Price vs 200-day SMA	69.65%
RSI	82.33
RSI Monthly	58.01
RSI Weekly	72.03
Sharpe ratio	1.31x
Sortino ratio	2.78
Total Return	0.32%
Tr YTD	64.79
Tr1m	72.06%
Tr1w	50%
Tr3m	44.44%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	IDR -6.9B
Operating margin	-72.29

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	646,220,400%
Net Borrowing	1,319,906,048
Shares Insiders	58.64%
Shares Out	1,562,500,000
Shares Qo Q	-1.07%
Shares Yo Y	-0.32%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	IDR -4.9B
Average Volume	112,954,440x
Bv Per Share	31.12
CAPEX	IDR -2.1B
Ch1m	72.06
Ch1w	50
Ch1y	134
Ch3m	44.44
Ch3y	23.16
Ch6m	82.81
Change	34.48%
Change From Open	32.95
Close	87
Days Gap	1.15
Depreciation Amortization	3,950,661,686
Dollar Volume	120,165,903,000
Earnings Date	2026-04-30
EBIT	IDR -6.9B
EBITDA	IDR -3B
EPS	IDR -4
F Score	4
FCF	IDR -4.9B
FCF EV Yield	-2.58x
FCF Per Share	IDR -3.13
Financing CF	4,463,346,689
Fiscal Year End	December
Founded	2,010
Income Tax	IDR -221.9M
Investing CF	-1,755,566,405
Is Primary Listing	1
Last Earnings Date	2025-10-29
Last Report Date	2026-03-31
Ma150	73.47
Ma150ch	59.26%
Ma20	76.9
Ma20ch	52.15%
Net CF	-65,819,886
Open	88
Position In Range	100
Ppne	43,415,167,966
Price Date	2026-05-08
Ptbv Ratio	3.76
Relative Volume	9.12x
Revenue	9,582,580,544x
Tax By Revenue	-2.32x
Tr6m	82.81%
Volume	1,027,059,000

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does IDX/MEDS pay a dividend?

Capital-return profile for this ticker.

Performance

IDX/MEDS stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns IDX/MEDS?

Insider, institutional, and short-interest positioning.

Institutional ownership

n/a

Share of float held by funds and institutions

Insider ownership

+58.6%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

-0.3%

Negative means the company is buying back shares.

Technical

IDX/MEDS momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

82.3

Above 70: short-term overbought

Price vs 200-day MA

+69.7%

50/200-day relationship not available

Beta (5Y)

1.17

Moves roughly with the market

Sharpe ratio

1.31

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About IDX/MEDS

Hub-level FAQ points readers to the deeper analysis pages.

What is the current idx/MEDS stock rating?

idx/MEDS is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full idx/MEDS analysis?

The full report lives at /stocks/idx/MEDS/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for idx/MEDS?

The latest report frames idx/MEDS around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the idx/MEDS page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.